Specialty Societies Increasingly Hold Key To Reimbursement, Insiders Say
This article was originally published in The Gray Sheet
Physician specialty societies are becoming increasingly influential in device reimbursement decisions, say industry insiders
You may also be interested in...
Reimbursement for uterine fibroid treatments get a boost in CMS' 2008 hospital outpatient 1rule, fueling industry expectations for increased market penetration by device-based alternatives to surgery
A coalition of professional societies is preparing to ask CMS to reconsider its national Medicare coverage policy on carotid stents and agree to cover the entire FDA-approved indication for the devices, according to the Society for Cardiovascular Angiography and Intervention
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.